Skip to main content

Table 2 Allele odds ratios analysis between probable SARS patients and other groups

From: Association of HLA class I with severe acute respiratory syndrome coronavirus infection

  33 Cases
Probable
SARS
patients
28 fever
patients
Control A
101 high risk non-infected
health care workers
Control B
190 healthy unrelated Taiwanese
HLA alleles Total number of alleles
n = 66
Total number of alleles
n = 56
P Total number of alleles
n = 202
OR CI P Total number of alleles
n = 380
OR CI P
B* 4601/B46 15 9 n.s. 25 2.08 1.04–4.24 0.04 52 1.86 1.02–3.54 0.06
B* 1301/B13 1 3 n.s. 18 0.16 0.02–1.00 0.03 34 0.16 0.02–0.97 0.02
B* 5401/B54 5 3 n.s. 3 5.44 1.26–23.41 0.02 15 1.99 1.01–5.69 n.s.
B* 3901/B39 5 2 n.s. 6 2.68 0.78–9.08 n.s. 8 3.81 1.21–12.03 0.03
  1. P = P-value n.s. = not significant. In control B, HLA-A and B were defined by serological methods. Consequently data were re-analyzed after converting allotypes of probable SARS patients to their serological equivalents [8]. Odds ratio (OR) refers to Woolf-Haldane odds ratios, with 95% Woolf approximation confidence intervals (CI) and corresponding two tails Fisher P-values. Note: No corrected P-values (Pc-values) were significant; consequently Pc-values were not indicated.